Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis by J. Ventriglia, A. Petrillo, M. Huerta Alváro, M. M. Laterza, B. Savastano, V. Gambardella, G. Tirino, L. Pompella, A. Diana, F. Iovino, T. Troiani, E. Martinelli, F. Morgillo, M. Orditura, A. Cervantes, F. Ciardiello, F. De Vita

Get full text

Off-label drug use in oncology: integrating molecular and genetic analysis in an academic center’s real-world approach by E. Cioli, G. Suarato, R. Napolitano, F. Caraglia, A. Esposito, C.M. Giugliano, S. Cozzolino, M. Forte, M.P. Laudato, E. Martinelli, F. De Vita, F. Morgillo, M. Orditura, M. Fasano, S. Napolitano, C.M. Della Corte, G. Martini, F. Ciardiello, T. Troiani, V. De Falco

Get full text